Clinical Trial Update: Options for Delivering Isoniazid-Rifapentine (3HP) for TB Prevention (3HP Options Implementation Trial) [NA]

View source ↗

Summary

An implementation trial compared different delivery methods for the 3HP regimen (isoniazid–rifapentine) to prevent tuberculosis in individuals with latent TB in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Latent Tuberculosis Infection
• Tuberculosis

Drugs mentioned

• ISONIAZID (ISONIAZID)
• rifapentine (rifapentine)

Snippet

Sponsor: University of California, San Francisco | Conditions: Tuberculosis, Latent Tuberculosis | NA | Status: COMPLETED | Results posted: 2023-11-07